COVID-19 vaccines for all: Will Sputnik V speed up vaccination in India

Sputnik V’s entry may not dent the ongoing vaccine shortage in India, but its domestic production could change things by year-end

There's an unhealthy alliance between doctors and pharma firms

The government has shown little interest to penalise pharma companies that offer sops to doctors to push their drugs

It is critical to view antimicrobial resistance through a multi-dimensional lens

Reducing pollution from the pharmaceutical, agricultural and healthcare sectors is needed to reduce the emergence, transmission and spread of …

India: the pharmacy of the world where ‘crazy drug combinations’ go unregulated

Of 175 drug combinations used to treat pain-relief, diabetes, anxiety/depression, and psychosis, a study found that 115 combinations had no …

'India’s drug dependence on China not good for its health sector'

Setting up of large-scale pharma and chemical clusters in proximity to each other can help sector perform better, says industry body ASSOCHAM

This is how rich nations protect profits of multinational pharma firms

When rich nations insist on patent linkage provisions in bilateral and regional trade pacts, there is a way out

After cough-syrup, now eye drops: India-made solution causes 1 death, several infections in US

This could be particularly damning for India’s drug regulatory system since it is coming on the heels of cough-syrup-associated deaths in …

New hepatitis drug to cost more in middle income nations; activists cry foul

Pharma company’s strategy of different prices for different countries to affect quality treatment of 185 million people infected with …

How dosage of fever drugs has again highlighted nexus of pharma firms, doctors

No regulation on marketing strategies by drug companies has created a medical autocracy, the Dolo-650 controversy shows

Modi Cabinet approves 100% FDI in medical devices sector via automatic route

Existing conditions and prior approval required in case of merger and acquisition done away with

2022 Chemistry Nobel awarded for ‘click chemistry’, which has possible applications in healthcare

Carolyn Bertozzi, Morten Meldal and Barry Sharpless worked on click chemistry, or linking chemicals together, and biorthogonal reactions, …

Sun-Ranbaxy merger: CCI says deal may hurt competition, seeks public opinion

The merger would lead to creation of the world's fifth-largest maker of generic drugs

Sun Pharma, Novartis settle lawsuit over Glivec

Sun Pharma allowed to launch generic version of anti-leukamia drug next year

That which is injurious to health

Book>> Bad Pharma • by Ben Goldacre • Fourth Estate • £13

No veterinary drug given to Jodhpur hospital; just a case of wrong labelling, says company

Rajasthan government sets up committee to probe administration of injections from vials labelled 'for animal treatment'

Industries can harm health in many ways: Here are 3 that aren’t so obvious

Some products and practices are directly linked to avoidable ill health, planetary damage and social and health inequity, especially by …

Ban FDI in brownfield pharma, says Parliament standing committee

Panel raises alarm over continuing takeover of Indian generic drug firms by multinational companies

The NATCO CL fallout

The compulsory licence granted to Natco may not be a trendsetter but it will shake up the pharmaceuticals market

Pharma lobby obtains stay on Centre’s drug price control order

Drug manufacturers also trying to scuttle government’s drug pricing policy

Maharashtra bans anti-tick medication temporarily

26 heads of cattle killed after being administered injection in Parbhani district

A patent triumph of public interest

New flexibilities make public interest safeguards integral to drug patent rights

CAG exposes land scam in Andhra

Government largesse to private enterprises and individuals cost exchequer Rs 1,784 crore

US keeps India out of Priority Foreign Country list of 'worst IP offenders'

US Trade Representative’s Special 301 Report keeps up pressure on India to fall in line with US’ interests

The natco-pfizer test

Natco’s demand for a voluntary licence from Pfizer will establish how well the compulsory licence process works in India

Drug affordability test

Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …